Open-label Clinical Trial of Niraparib Combined With Pembrolizumab for Treatment of Advanced or Metastatic Triple-Negative Breast Cancer

Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg, +17

JAMA Oncology

Cediranib, an Oral Inhibitor of Vascular Endothelial Growth Factor Receptor Kinases, Is an Active Drug in Recurrent Epithelial Ovarian, Fallopian Tube, and Peritoneal Cancer

Ursula A. Matulonis, Suzanne Berlin, Percy Ivy, +16

Journal of Clinical Oncology

Avelumab in patients with previously treated metastatic adrenocortical carcinoma: phase 1b results from the JAVELIN solid tumor trial

Christophe Le Tourneau, Christopher Hoimes, Corrine Zarwan, +9

Journal for ImmunoTherapy of Cancer

Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update

Jennifer J. Griggs, Kari Bohlke, Edward P. Balaban, +14

Journal of Clinical Oncology

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley, +328

The Lancet Oncology

Advanced Ovarian CancerMedicinePharmacologyGynecologyFirst-line Treatment +7

Upfront dexrazoxane for the reduction of anthracycline-induced cardiotoxicity in adults with preexisting cardiomyopathy and cancer: a consecutive case series

Sarju Ganatra, Anju Nohria, Sachin Shah, +13

Cardio-Oncology

TOPACIO/Keynote-162: Niraparib + pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC), a phase 2 trial.

Shaveta Vinayak, Sara M. Tolaney, Lee S. Schwartzberg, +17

Journal of Clinical Oncology

Breast OncologyOncologyImmunologyPharmacologyPathology +13

Selective Blockade of Matrix Metalloprotease-14 with a Monoclonal Antibody Abrogates Invasion, Angiogenesis, and Tumor Growth in Ovarian Cancer

Rajani Kaimal, Raid Aljumaily, Sarah L. Tressel, +7

Cancer Research

Selective BlockadeAngiogenesisMedicineTumor GrowthImmunology +13

Fusions of Dendritic Cells with Breast Carcinoma Stimulate the Expansion of Regulatory T Cells while Concomitant Exposure to IL-12, CpG Oligodeoxynucleotides, and Anti-CD3/CD28 Promotes the Expansion of Activated Tumor Reactive Cells

Baldev Vasir, Zekui Wu, Keith Crawford, +5

The Journal of Immunology

Immunomodulatory effects of vitamin D: implications for GVHD

Jacalyn Rosenblatt, Adam Bissonnette, Rehan Ahmad, +13

Bone Marrow Transplantation

Autoimmune DiseaseClinical NutritionImmunologyAutoimmunityImmunosuppression +2